Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luigi Aurisicchio

Showing results (1-10 of 93) with videos related to

Pageof 10
Sort By:
Cancers|November 12, 2013
Emerging cancer vaccines: the promise of genetic vectorsLuigi Aurisicchio, Gennaro Ciliberto
Expert Opinion on Therapeutic Patents|March 30, 2010
Patented cancer vaccines: the promising leadsLuigi Aurisicchio, Gennaro Ciliberto
Expert Opinion on Biological Therapy|May 15, 2012
Genetic cancer vaccines: current status and perspectivesLuigi Aurisicchio, Gennaro Ciliberto
Expert Opinion on Biological Therapy|August 4, 2009
Engineered adenovirus serotypes for overcoming anti-vector immunitySridhar Dharmapuri, Daniela Peruzzi, Luigi Aurisicchio
Expert Review of Vaccines|September 27, 2013
Cancer vaccination by electro-gene-transferLuigi Aurisicchio, Rita Mancini, Gennaro Ciliberto
Journal of Virology|July 29, 2004
Baculovirus vectors elicit antigen-specific immune responses in miceAndrea Facciabene, Luigi Aurisicchio, Nicola La Monica
Expert Opinion on Biological Therapy|July 16, 2014
Xenogene vaccination in the therapy of cancerFederica Cavallo, Luigi Aurisicchio, Rita Mancini, et al.
Journal of Cellular Physiology|May 4, 2012
Kinesin spindle protein SiRNA slows tumor progressionEmanuele Marra, Fabio Palombo, Gennaro Ciliberto, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 22, 2018
The perfect personalized cancer therapy: cancer vaccines against neoantigensLuigi Aurisicchio, Matteo Pallocca, Gennaro Ciliberto, et al.
Journal of Immunological Methods|October 3, 2006
Individual mouse analysis of the cellular immune response to tumor antigens in peripheral blood by intracellular staining for cytokinesPatrizia Giannetti, Andrea Facciabene, Nicola La Monica, et al.
Pageof 10

Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
Cancers|November 12, 2013
Emerging cancer vaccines: the promise of genetic vectorsLuigi Aurisicchio, Gennaro Ciliberto
Expert Opinion on Therapeutic Patents|March 30, 2010
Patented cancer vaccines: the promising leadsLuigi Aurisicchio, Gennaro Ciliberto
Expert Opinion on Biological Therapy|May 15, 2012
Genetic cancer vaccines: current status and perspectivesLuigi Aurisicchio, Gennaro Ciliberto
Expert Opinion on Biological Therapy|August 4, 2009
Engineered adenovirus serotypes for overcoming anti-vector immunitySridhar Dharmapuri, Daniela Peruzzi, Luigi Aurisicchio
Expert Review of Vaccines|September 27, 2013
Cancer vaccination by electro-gene-transferLuigi Aurisicchio, Rita Mancini, Gennaro Ciliberto
Journal of Virology|July 29, 2004
Baculovirus vectors elicit antigen-specific immune responses in miceAndrea Facciabene, Luigi Aurisicchio, Nicola La Monica
Expert Opinion on Biological Therapy|July 16, 2014
Xenogene vaccination in the therapy of cancerFederica Cavallo, Luigi Aurisicchio, Rita Mancini, et al.
Journal of Cellular Physiology|May 4, 2012
Kinesin spindle protein SiRNA slows tumor progressionEmanuele Marra, Fabio Palombo, Gennaro Ciliberto, et al.
Journal of Experimental & Clinical Cancer Research : CR|April 22, 2018
The perfect personalized cancer therapy: cancer vaccines against neoantigensLuigi Aurisicchio, Matteo Pallocca, Gennaro Ciliberto, et al.
Journal of Immunological Methods|October 3, 2006
Individual mouse analysis of the cellular immune response to tumor antigens in peripheral blood by intracellular staining for cytokinesPatrizia Giannetti, Andrea Facciabene, Nicola La Monica, et al.
Pageof 10